Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

DarioHealth Corp

DRIO
Current price
0.92 USD -0.05 USD (-5.15%)
Last closed 0.97 USD
ISIN US23725P2092
Sector Healthcare
Industry Health Information Services
Exchange NASDAQ
Capitalization 29 923 368 USD
Yield for 12 month -14.02 %
1Y
3Y
5Y
10Y
15Y
DRIO
21.11.2021 - 28.11.2021

DarioHealth Corp. operates as a digital health company in the United States, Canada, the European Union, Australia, and New Zealand. Its digital therapeutics platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health. The company offers Dario Evolve, a metabolic solution to address metabolic health needs, such as diabetes, pre-diabetes, hypertension, and weight management; Dario Move, which address most common musculoskeletal conditions; Dario Elevate, a behavioral health solution that optimizes access to evidence-based care; and Dario One, a full suite of chronic condition management solution; and Dario blood glucose monitoring systems. It also provides native devices, such as glucose meter, blood pressure cuff, digital scale, and biofeedback sensor device, as well as live coaching services. The company was formerly known as LabStyle Innovations Corp. and changed its name to DarioHealth Corp. in July 2016. DarioHealth Corp. was incorporated in 2011 and is based in New York, New York. Address: 122 W 57th St,, New York, NY, United States, 10019

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

3.83 USD

P/E ratio

Dividend Yield

Current Year

+20 352 000 USD

Last Year

+27 656 000 USD

Current Quarter

+6 255 000 USD

Last Quarter

+5 758 000 USD

Current Year

+5 984 000 USD

Last Year

+9 655 000 USD

Current Quarter

+2 756 000 USD

Last Quarter

+2 432 000 USD

Key Figures DRIO

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -57 959 000 USD
Operating Margin TTM -258.85 %
PE Ratio
Return On Assets TTM -33.26 %
PEG Ratio
Return On Equity TTM -69.37 %
Wall Street Target Price 3.83 USD
Revenue TTM 19 147 000 USD
Book Value 2.27 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY 1.7 %
Dividend Yield
Gross Profit TTM 14 012 000 USD
Earnings per share -1.13 USD
Diluted Eps TTM -1.13 USD
Most Recent Quarter II 2024
Quarterly Earnings Growth YOY
Profit Margin -265.33 %

Dividend Analytics DRIO

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History DRIO

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor 1:20
Payout Ratio
Last Split Date 18.11.2019
Dividend Date 18.11.2019

Stock Valuation DRIO

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue 1.952
Price Sales TTM 1.5628
Enterprise Value EBITDA -0.5861
Price Book MRQ 0.4361

Financials DRIO

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators DRIO

For 52 weeks

0.71 USD 2.6 USD
50 Day MA 0.94 USD
Shares Short Prior Month 1 772 251
200 Day MA 1.35 USD
Short Ratio 17.01
Shares Short 1 764 706
Short Percent 6.57 %